38.900
+0,00%
2026-10-12
Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -17.3% | +344.3% | 2 / 3 | +23.2% | -0.66 pp | -2.07 pp | +20.5% | 0.25 | 18.78 | 73,5 | +23,2% | 3,1 | −17,3% | 18.78 | 20.45 | −8,2% |
| Pts | 0 | 12 | 8 | 12 | 4 | 0 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 38.900 (close price on 2026-10-12)EPS (TTM): 2.071
Financial charts
1.Revenue & growth
VND bn73,5Q2/26
1.Revenue & growth
VND bn73,5Q2/26
2.Profit & growth
VND bn3,10Q2/26
3.Profit mix (Penman)
VND bn10,3Q2/26
4.Margins & cost structure
%16.9%Q2/26
5.Returns & cash cycle
% · days42.6%Q2/26
6.Earnings quality & cash
VND bn29,0Q2/26
7.Asset structure
VND bn125Q2/26
8.Funding & debt health
VND bn · times125Q2/26
9.Revenue backlog
VND bn11,9Q2/26
10.Valuation
times · %18,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %727Q2/26
Adjusted EPS growth, latest quarter
-17.3%
Average adjusted EPS growth, 3 quarters
344%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26